Zydus Lifesciences
₹1,135.00Change from previous close: −0.93%Absolute change: −₹10.70
Valuation
Data as of October 5, 2026
Valuation multiples
- Market cap
- ₹1.14T
- Enterprise value
- ₹1.25T
- P/E (trailing 12 months)
- 25.6
- Forward P/E
- 23.3
- PEG
- 11.4
- Price/book
- 4.25
- Price/sales
- 4.00
- EV/EBITDA
- 18.4
- EV/revenue
- 4.38
Profitability and growth
- Gross margin
- 72.1%
- Operating margin
- 16.4%
- Net margin
- 15.8%
- ROIC
- 10.8%
- Revenue growth (year over year)
- 22.0%
- Earnings growth (year over year)
- -35.9%
Financial health
- Total cash
- ₹49.71B
- Total debt
- ₹125.15B
- Debt/equity
- 0.42
- Piotroski F-Score
- 3.00
Dividends
- Annual dividend per share
- ₹1.00
- Dividend yield
- 0.1%
- Payout ratio
- 24.5%
- Ex-dividend date
- July 24, 2026
Analysts and estimates
- Average price target
- ₹1,197.45
- Median price target
- ₹1,201.50
- High price target
- ₹1,457.48
- Low price target
- ₹800.00
- Analysts with a price target
- 30
- Consensus
- Hold
- Forward EPS
- ₹49.19
- EPS estimate, current year
- ₹40.63
Shares and trading
- Beta
- 0.37
- Average volume
- 1.49M
- Shares outstanding
- 997.5M
- Float
- 242.88M
- Institutional ownership
- 16.3%
- Insider ownership
- 75.2%